18
Views
7
CrossRef citations to date
0
Altmetric
Review

Fluoropyrimidine resistance in colon cancer

&
Pages 409-416 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Farid E Ahmed. (2005) Molecular markers that predict response to colon cancer therapy. Expert Review of Molecular Diagnostics 5:3, pages 353-375.
Read now

Articles from other publishers (6)

Brian Youden, Runqing Jiang, Andrew J. Carrier, Mark R. Servos & Xu Zhang. (2022) A Nanomedicine Structure–Activity Framework for Research, Development, and Regulation of Future Cancer Therapies. ACS Nano 16:11, pages 17497-17551.
Crossref
Jianxia Li, Yue Cai & Yanhong Deng. (2021) Selection of Oral Therapeutics in China for the Treatment of Colorectal Cancer. Current Treatment Options in Oncology 22:7.
Crossref
Priyanka Sharma, Tadanobu Shimura, Jasjit K Banwait & Ajay Goel. (2020) Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer. Carcinogenesis 41:10, pages 1385-1394.
Crossref
Satya Das, Kristen K. Ciombor, Sigurdis Haraldsdottir & Richard M. Goldberg. (2018) Promising New Agents for Colorectal Cancer. Current Treatment Options in Oncology 19:6.
Crossref
Rita Humeniuk, Lata G. Menon, Prasun J. Mishra, Richard Gorlick, Rebecca Sowers, Wojciech Rode, Giuseppe Pizzorno, Yung-Chi Cheng, Nancy Kemeny, Joseph R. Bertino & Debabrata Banerjee. (2009) Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance. Molecular Cancer Therapeutics 8:5, pages 1037-1044.
Crossref
Jens Martin Werner, Kurt Eger & Hans Jürgen Steinfelder. (2006) Comparison of the rapid pro-apoptotic effect of trans-ß-nitrostyrenes with delayed apoptosis induced by the standard agent 5-fluorouracil in colon cancer cells. Apoptosis 12:1, pages 235-246.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.